Health-related quality of life (HRQoL) for olaparib versus enzalutamide or abiraterone in metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair (HRR) gene alterations: PROfound.

Affiliation auteurs!!!! Error affiliation !!!!
TitreHealth-related quality of life (HRQoL) for olaparib versus enzalutamide or abiraterone in metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair (HRR) gene alterations: PROfound.
Type de publicationJournal Article
Year of Publication2020
AuteursThiery-Vuillemin A, De Bono JS, Saad F, Procopio G, Shore ND, Fizazi K, Roubaud G, Anjos Gdos, Gravis G, Joung JYoung, Matsubara N, Castellano D, Degboe A, Gresty C, Kang J, Allen A, Burgents JE, Hussain MHA
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume38
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X